Global Silk Fibroin (SF) Market Size, Share, Trends and Forecast 2022-2030

Description

Silk fibroin is a nature biomaterial derived from cocoon and silk. Studies have found that silk fibroin have the advantages of green processing, excellent biocompatibility, high molecular weight, and tissue repair characteristic.
Industry Insights

Due to the COVID-19 pandemic, the global Silk Fibroin (SF) market size is estimated to be worth US$ 94 million in 2021 and is forecast to a readjusted size of US$ 147.8 million by 2028 with a CAGR of 6.6% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Silk Fibroin (SF) market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Silk Fibroin (SF) landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

On the basis of product type, Type of Silk Amino Acidsrepresent the largest share of the worldwide Silk Fibroin (SF) market, with 40% share. In the applications, Cosmetic & Personal Care segment is estimated to be the largest end-use industry segment of the market in 2019, with 71% share of global market. Asia Pacific holds the major share in the market, with a share of 60%.

This report focuses on Silk Fibroin (SF) volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Silk Fibroin (SF) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: Europe, China and India, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Silk Fibroin (SF) market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

Silk Fibroin Powder

Silk Amino Acids

Silk Peptide

Segment by Application

Cosmetic & Personal Care

Biomedical

Supplements

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Huzhou Silkspark Bio-tech Co. Ltd

LANXESS

Hanzhou Linran

Huzhou Xintiansi Bio-tech

Chongqing Haifan Biochemical

Zhejiang Silk Seekers Biotechnology

Seidecosa

Suzhou Suhao Bio

Caresilk

Kelisema Srl

TABLE OF CONTENT

1 Silk Fibroin (SF) Market Overview
1.1 Product Overview and Scope of Silk Fibroin (SF)

1.2 Silk Fibroin (SF) Segment by Type

1.2.1 Global Silk Fibroin (SF) Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 Silk Fibroin Powder

1.2.3 Silk Amino Acids

1.2.4 Silk Peptide

1.3 Silk Fibroin (SF) Segment by Application

1.3.1 Global Silk Fibroin (SF) Sales Comparison by Application: (2022-2028)

1.3.2 Cosmetic & Personal Care

1.3.3 Biomedical

1.3.4 Supplements

1.4 Global Silk Fibroin (SF) Market Size Estimates and Forecasts

1.4.1 Global Silk Fibroin (SF) Revenue 2017-2028

1.4.2 Global Silk Fibroin (SF) Sales 2017-2028

1.4.3 Silk Fibroin (SF) Market Size by Region: 2017 Versus 2021 Versus 2028

2 Silk Fibroin (SF) Market Competition by Manufacturers

2.1 Global Silk Fibroin (SF) Sales Market Share by Manufacturers (2017-2022)

2.2 Global Silk Fibroin (SF) Revenue Market Share by Manufacturers (2017-2022)

2.3 Global Silk Fibroin (SF) Average Price by Manufacturers (2017-2022)

2.4 Manufacturers Silk Fibroin (SF) Manufacturing Sites, Area Served, Product Type

2.5 Silk Fibroin (SF) Market Competitive Situation and Trends

2.5.1 Silk Fibroin (SF) Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Silk Fibroin (SF) Players Market Share by Revenue

2.5.3 Global Silk Fibroin (SF) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Silk Fibroin (SF) Retrospective Market Scenario by Region

3.1 Global Silk Fibroin (SF) Retrospective Market Scenario in Sales by Region: 2017-2022

3.2 Global Silk Fibroin (SF) Retrospective Market Scenario in Revenue by Region: 2017-2022

3.3 North America Silk Fibroin (SF) Market Facts & Figures by Country

3.3.1 North America Silk Fibroin (SF) Sales by Country

3.3.2 North America Silk Fibroin (SF) Revenue by Country

3.3.3 U.S.

3.3.4 Canada

3.4 Europe Silk Fibroin (SF) Market Facts & Figures by Country

3.4.1 Europe Silk Fibroin (SF) Sales by Country

3.4.2 Europe Silk Fibroin (SF) Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Silk Fibroin (SF) Market Facts & Figures by Region

3.5.1 Asia Pacific Silk Fibroin (SF) Sales by Region

3.5.2 Asia Pacific Silk Fibroin (SF) Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.5.12 Philippines

3.5.13 Vietnam

3.6 Latin America Silk Fibroin (SF) Market Facts & Figures by Country

3.6.1 Latin America Silk Fibroin (SF) Sales by Country

3.6.2 Latin America Silk Fibroin (SF) Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Silk Fibroin (SF) Market Facts & Figures by Country

3.7.1 Middle East and Africa Silk Fibroin (SF) Sales by Country

3.7.2 Middle East and Africa Silk Fibroin (SF) Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global Silk Fibroin (SF) Historic Market Analysis by Type

4.1 Global Silk Fibroin (SF) Sales Market Share by Type (2017-2022)

4.2 Global Silk Fibroin (SF) Revenue Market Share by Type (2017-2022)

4.3 Global Silk Fibroin (SF) Price by Type (2017-2022)

5 Global Silk Fibroin (SF) Historic Market Analysis by Application

5.1 Global Silk Fibroin (SF) Sales Market Share by Application (2017-2022)

5.2 Global Silk Fibroin (SF) Revenue Market Share by Application (2017-2022)

5.3 Global Silk Fibroin (SF) Price by Application (2017-2022)

6 Key Companies Profiled

6.1 Huzhou Silkspark Bio-tech Co. Ltd

6.1.1 Huzhou Silkspark Bio-tech Co. Ltd Corporation Information

6.1.2 Huzhou Silkspark Bio-tech Co. Ltd Description and Business Overview

6.1.3 Huzhou Silkspark Bio-tech Co. Ltd Silk Fibroin (SF) Sales, Revenue and Gross Margin (2017-2022)

6.1.4 Huzhou Silkspark Bio-tech Co. Ltd Silk Fibroin (SF) Product Portfolio

6.1.5 Huzhou Silkspark Bio-tech Co. Ltd Recent Developments/Updates

6.2 LANXESS

6.2.1 LANXESS Corporation Information

6.2.2 LANXESS Description and Business Overview

6.2.3 LANXESS Silk Fibroin (SF) Sales, Revenue and Gross Margin (2017-2022)

6.2.4 LANXESS Silk Fibroin (SF) Product Portfolio

6.2.5 LANXESS Recent Developments/Updates

6.3 Hanzhou Linran

6.3.1 Hanzhou Linran Corporation Information

6.3.2 Hanzhou Linran Description and Business Overview

6.3.3 Hanzhou Linran Silk Fibroin (SF) Sales, Revenue and Gross Margin (2017-2022)

6.3.4 Hanzhou Linran Silk Fibroin (SF) Product Portfolio

6.3.5 Hanzhou Linran Recent Developments/Updates

6.4 Huzhou Xintiansi Bio-tech

6.4.1 Huzhou Xintiansi Bio-tech Corporation Information

6.4.2 Huzhou Xintiansi Bio-tech Description and Business Overview

6.4.3 Huzhou Xintiansi Bio-tech Silk Fibroin (SF) Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Huzhou Xintiansi Bio-tech Silk Fibroin (SF) Product Portfolio

6.4.5 Huzhou Xintiansi Bio-tech Recent Developments/Updates

6.5 Chongqing Haifan Biochemical

6.5.1 Chongqing Haifan Biochemical Corporation Information

6.5.2 Chongqing Haifan Biochemical Description and Business Overview

6.5.3 Chongqing Haifan Biochemical Silk Fibroin (SF) Sales, Revenue and Gross Margin (2017-2022)

6.5.4 Chongqing Haifan Biochemical Silk Fibroin (SF) Product Portfolio

6.5.5 Chongqing Haifan Biochemical Recent Developments/Updates

6.6 Zhejiang Silk Seekers Biotechnology

6.6.1 Zhejiang Silk Seekers Biotechnology Corporation Information

6.6.2 Zhejiang Silk Seekers Biotechnology Description and Business Overview

6.6.3 Zhejiang Silk Seekers Biotechnology Silk Fibroin (SF) Sales, Revenue and Gross Margin (2017-2022)

6.6.4 Zhejiang Silk Seekers Biotechnology Silk Fibroin (SF) Product Portfolio

6.6.5 Zhejiang Silk Seekers Biotechnology Recent Developments/Updates

6.7 Seidecosa

6.6.1 Seidecosa Corporation Information

6.6.2 Seidecosa Description and Business Overview

6.6.3 Seidecosa Silk Fibroin (SF) Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Seidecosa Silk Fibroin (SF) Product Portfolio

6.7.5 Seidecosa Recent Developments/Updates

6.8 Suzhou Suhao Bio

6.8.1 Suzhou Suhao Bio Corporation Information

6.8.2 Suzhou Suhao Bio Description and Business Overview

6.8.3 Suzhou Suhao Bio Silk Fibroin (SF) Sales, Revenue and Gross Margin (2017-2022)

6.8.4 Suzhou Suhao Bio Silk Fibroin (SF) Product Portfolio

6.8.5 Suzhou Suhao Bio Recent Developments/Updates

6.9 Caresilk

6.9.1 Caresilk Corporation Information

6.9.2 Caresilk Description and Business Overview

6.9.3 Caresilk Silk Fibroin (SF) Sales, Revenue and Gross Margin (2017-2022)

6.9.4 Caresilk Silk Fibroin (SF) Product Portfolio

6.9.5 Caresilk Recent Developments/Updates

6.10 Kelisema Srl

6.10.1 Kelisema Srl Corporation Information

6.10.2 Kelisema Srl Description and Business Overview

6.10.3 Kelisema Srl Silk Fibroin (SF) Sales, Revenue and Gross Margin (2017-2022)

6.10.4 Kelisema Srl Silk Fibroin (SF) Product Portfolio

6.10.5 Kelisema Srl Recent Developments/Updates

7 Silk Fibroin (SF) Manufacturing Cost Analysis

7.1 Silk Fibroin (SF) Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Silk Fibroin (SF)

7.4 Silk Fibroin (SF) Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 Silk Fibroin (SF) Distributors List

8.3 Silk Fibroin (SF) Customers

9 Silk Fibroin (SF) Market Dynamics

9.1 Silk Fibroin (SF) Industry Trends

9.2 Silk Fibroin (SF) Market Drivers

9.3 Silk Fibroin (SF) Market Challenges

9.4 Silk Fibroin (SF) Market Restraints

10 Global Market Forecast

10.1 Silk Fibroin (SF) Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Silk Fibroin (SF) by Type (2023-2028)

10.1.2 Global Forecasted Revenue of Silk Fibroin (SF) by Type (2023-2028)

10.2 Silk Fibroin (SF) Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Silk Fibroin (SF) by Application (2023-2028)

10.2.2 Global Forecasted Revenue of Silk Fibroin (SF) by Application (2023-2028)

10.3 Silk Fibroin (SF) Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Silk Fibroin (SF) by Region (2023-2028)

10.3.2 Global Forecasted Revenue of Silk Fibroin (SF) by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

Choose License Type

Checkout Inquiry Sample